RxDoctor Payments Data

Kelli Quercetti, DO

Otolaryngology/Facial Plastic Surgery · Chester, PANPI 1285954388

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $367 and has fallen 73.4% since, to $98 in 2025. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in PA, where the typical reported total is $3,163.

$1,175in general payments, 2019–2025

Across 45 payments — averaging $26.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$259
  • Optinose US, Inc.$239
  • GSK$176
  • Regeneron Healthcare Solutions, Inc.$137
  • Axogen$67
  • Pfizer$60
  • plus $237 from 10 others

What the payments were for

  • Food & beverage$1,175100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,175 in reported general payments places this provider in the 30th percentile of 21 otolaryngology/facial plastic surgery providers in Pennsylvania.

See all otolaryngology/facial plastic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$148,838
Medicare patients
590
Services billed
2,048

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl144$3,734
Ipratropium Bromide67$2,050
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth15$1,721
Fluticasone Propionate71$1,113
Omeprazole77$970
Famotidine156$953
Ofloxacin14$343
Mometasone Furoate24$319
Mupirocin31$207
Methylprednisolone27$175
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$157

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Chester

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →